𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Enhancement of tumor outgrowth by tumor-associated blocking factors

✍ Scribed by K. E. Hellström; I. Hellström


Book ID
102869317
Publisher
John Wiley and Sons
Year
1979
Tongue
French
Weight
651 KB
Volume
23
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Transplanted lines of 3‐methylcholanthrene (MCA)‐induced BALB/c sarcomas were used for experiments in which tumors were mechanically suspended in Waymouth's culture medium, the suspensions centrifuged and filtered and the remaining cell‐free “tumor fluids” (TF) tested for activity in vitro and in vivo. TF were found to inhibit (“block”) cell‐mediated cytotoxicity to tumor target cells in vitro with specificity for each tumor tested and even at high dilutions (1:1,000–1:10,000). In vivo, TF enhanced the outgrowth of subcutaneously transplanted tumors in non‐immune syngeneic mice. This enhancement had both specific and non‐specific components, with the non‐specific component being most apparent. Enhancement was best demonstrated when the TF were inoculated together with the tumor inocula. In one of two experiments in which TF were given intraperitoneally, specific enhancement was seen, whereas in the other, inhibition of tumor outgrowth was observed.


📜 SIMILAR VOLUMES


Tumor-associated immunoglobulins. enhanc
✍ Maya Ran; Isaac P. Witz 📂 Article 📅 1972 🏛 John Wiley and Sons 🌐 French ⚖ 462 KB

## Abstract The present study was intended to establish whether IgG2‐containing eluates, dissociated from carcinogen‐induced tumors by a low pH buffer, have tumor‐enhancing properties. Threshold amounts of cells from mouse tumor lines originally induced by benzo (a)‐pyrene or by methylcholanthrene

Serum factors in tumor-free patients can
✍ Ingegerd Hellström; Karl Erik Hellström; Hans Olov Sjögren; Glenn A. Warner 📂 Article 📅 1971 🏛 John Wiley and Sons 🌐 French ⚖ 486 KB 👁 1 views

## Abstract It has been previously shown that lymphocytes from cancer patients can kill cultivated neoplastic cells of the type carried by the lymphocyte donors and that sera from patients with growing tumors of the respective types can specifically block the tumor‐cell destruction. The present stu